Literature DB >> 12735493

Maximum penalized likelihood estimation in a gamma-frailty model.

Virginie Rondeau1, Daniel Commenges, Pierre Joly.   

Abstract

The shared frailty models allow for unobserved heterogeneity or for statistical dependence between observed survival data. The most commonly used estimation procedure in frailty models is the EM algorithm, but this approach yields a discrete estimator of the distribution and consequently does not allow direct estimation of the hazard function. We show how maximum penalized likelihood estimation can be applied to nonparametric estimation of a continuous hazard function in a shared gamma-frailty model withright-censored and left-truncated data. We examine the problem of obtaining variance estimators for regression coefficients, the frailty parameter and baseline hazard functions. Some simulations for the proposed estimation procedure are presented. A prospective cohort (Paquid) with grouped survival data serves to illustrate the method which was used to analyze the relationship between environmental factors and the risk of dementia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735493      PMCID: PMC1961627          DOI: 10.1023/a:1022978802021

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  11 in total

1.  Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study.

Authors:  V Rondeau; D Commenges; H Jacqmin-Gadda; J F Dartigues
Journal:  Am J Epidemiol       Date:  2000-07-01       Impact factor: 4.897

2.  The dialysis encephalopathy syndrome. Possible aluminum intoxication.

Authors:  A C Alfrey; G R LeGendre; W D Kaehny
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

Review 3.  Frailty models for survival data.

Authors:  P Hougaard
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

4.  Score test of homogeneity for survival data.

Authors:  D Commenges; P K Andersen
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

5.  A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia.

Authors:  P Joly; D Commenges; L Letenneur
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

6.  Spline-based tests in survival analysis.

Authors:  R J Gray
Journal:  Biometrics       Date:  1994-09       Impact factor: 2.571

7.  Geographical relation between Alzheimer's disease and aluminum in drinking water.

Authors:  C N Martyn; D J Barker; C Osmond; E C Harris; J A Edwardson; R F Lacey
Journal:  Lancet       Date:  1989-01-14       Impact factor: 79.321

8.  A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia.

Authors:  Pierre Joly; Daniel Commenges; Catherine Helmer; Luc Letenneur
Journal:  Biostatistics       Date:  2002-09       Impact factor: 5.899

9.  Modelling age-specific risk: application to dementia.

Authors:  D Commenges; L Letenneur; P Joly; A Alioum; J F Dartigues
Journal:  Stat Med       Date:  1998-09-15       Impact factor: 2.373

10.  Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France.

Authors:  L Letenneur; D Commenges; J F Dartigues; P Barberger-Gateau
Journal:  Int J Epidemiol       Date:  1994-12       Impact factor: 7.196

View more
  16 in total

1.  Bias correction in the hierarchical likelihood approach to the analysis of multivariate survival data.

Authors:  Jihyoun Jeon; Li Hsu; Malka Gorfine
Journal:  Biostatistics       Date:  2011-11-15       Impact factor: 5.899

2.  Small sample bias in the gamma frailty model for univariate survival.

Authors:  Peter Barker; Robin Henderson
Journal:  Lifetime Data Anal       Date:  2005-06       Impact factor: 1.588

3.  Cause-Specific Hazard Regression for Competing Risks Data Under Interval Censoring and Left Truncation.

Authors:  Chenxi Li
Journal:  Comput Stat Data Anal       Date:  2016-07-14       Impact factor: 1.681

4.  Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.

Authors:  Marie Vigan; Jérôme Stirnemann; France Mentré
Journal:  AAPS J       Date:  2014-02-26       Impact factor: 4.009

5.  Dynamic clustering of hazard functions: an application to disease progression in chronic heart failure.

Authors:  Francesca Ieva; Anna Maria Paganoni; Teresa Pietrabissa
Journal:  Health Care Manag Sci       Date:  2016-02-04

6.  Recurrent Events Model Application in Determining the Risk Factors of Bipolar Disorder Recurrence.

Authors:  Mansour Rezaei; Seyed Reza Hashemi; Vahid Farnia; Sharmin Rahmani
Journal:  Iran J Psychiatry       Date:  2021-01

7.  Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.

Authors:  Benoit Liquet; Jean-François Timsit; Virginie Rondeau
Journal:  BMC Med Res Methodol       Date:  2012-06-15       Impact factor: 4.615

8.  Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death.

Authors:  Virginie Rondeau; Simone Mathoulin-Pélissier; Lucie Tanneau; Annie J Sasco; Gaétan Macgrogan; Marc Debled
Journal:  BMC Cancer       Date:  2010-12-31       Impact factor: 4.430

9.  Multilevel competing risk models to evaluate the risk of nosocomial infection.

Authors:  Martin Wolkewitz; Ben S Cooper; Mercedes Palomar-Martinez; Francisco Alvarez-Lerma; Pedro Olaechea-Astigarraga; Adrian G Barnett; Stephan Harbarth; Martin Schumacher
Journal:  Crit Care       Date:  2014-04-08       Impact factor: 9.097

10.  Primary squamous cell carcinomas in the thyroid gland: an individual participant data meta-analysis.

Authors:  Jae Keun Cho; Seung-Hoon Woo; Junoh Park; Min-Ji Kim; Han-Sin Jeong
Journal:  Cancer Med       Date:  2014-07-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.